A Phase 2 Trial of TAS 102 in Recurrent/Metastatic Nasopharyngeal Carcinoma
Latest Information Update: 18 Nov 2020
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Therapeutic Use
- 18 Nov 2020 New trial record